Literature DB >> 10523544

Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers.

M Yoshinouchi1, A Hongo, K Nakamura, J Kodama, S Itoh, H Sakai, T Kudo.   

Abstract

Integration of human papillomavirus (HPV) DNA occurs early in cancer development and is an important event in malignant transformation of cervical cancer. Integration of HPVs preferentially disrupts or deletes the E2 open reading frame, which results in the loss of its expression. The preferential disruption of the E2 gene causes the absence of the E2 gene sequences in the PCR product following integration. Twenty-two carcinomas positive for HPV type 16 (HPV-16) DNA were first tested for the disruption of the E2 gene by PCR. A specific fragment of the E2 gene was not amplified in 10 cases, suggesting integration of HPV DNA into the host genome. Next, multiplex PCR for the HPV E2 and E6 genes was carried out in the remaining 12 cases. Copy numbers of both genes should be equivalent in episomal forms, while the E2 gene copy number will be smaller than that for E6 following the preferential disruption of the E2 gene in concomitant forms. Although relative ratios of HPV E2 to E6 PCR products (E2/E6 ratios) ranged from 1.40 to 2.34 in 10 of 12 cases, multiplex PCR products from 2 cases displayed extremely low ratios of 0.69 and 0.61. Southern blot hybridization with an HPV-16 probe revealed that only in these two cases was both episomal and integrated HPV DNA being carried simultaneously. Thus, multiplex PCR for the E2 and E6 genes of HPV-16 DNA following PCR for the E2 gene can distinguish the pure episomal form from a mixed form of episomal and integrated HPV DNA. Clinical application of this technique will help researchers to understand the implication of the integration of HPV DNA for cervical carcinogenesis and cervical cancer progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523544      PMCID: PMC85682     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer.

Authors:  S D Vernon; E R Unger; D L Miller; D R Lee; W C Reeves
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

2.  Do HPV-negative cervical carcinomas exist?

Authors:  J M Walboomers; C J Meijer
Journal:  J Pathol       Date:  1997-03       Impact factor: 7.996

3.  Physical status and expression of HPV genes in cervical cancers.

Authors:  J S Park; E S Hwang; S N Park; H K Ahn; S J Um; C J Kim; S J Kim; S E Namkoong
Journal:  Gynecol Oncol       Date:  1997-04       Impact factor: 5.482

Review 4.  Papillomavirus infections--a major cause of human cancers.

Authors:  H zur Hausen
Journal:  Biochim Biophys Acta       Date:  1996-10-09

5.  A close correlation between c-erbB-2 gene amplification and local progression in endometrial adenocarcinoma.

Authors:  A Seki; K Nakamura; J Kodama; Y Miyagi; M Yoshinouchi; T Kudo
Journal:  Eur J Gynaecol Oncol       Date:  1998       Impact factor: 0.196

6.  Use of multiple PCR primer sets for optimal detection of human papillomavirus.

Authors:  F Karlsen; M Kalantari; A Jenkins; E Pettersen; G Kristensen; R Holm; B Johansson; B Hagmar
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

7.  Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas.

Authors:  A Seki; J Kodama; Y Miyagi; S Kamimura; M Yoshinouchi; T Kudo
Journal:  Int J Cancer       Date:  1997-09-26       Impact factor: 7.396

Review 8.  Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes.

Authors:  K Vousden
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

9.  Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene.

Authors:  E S Hwang; D J Riese; J Settleman; L A Nilson; J Honig; S Flynn; D DiMaio
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

View more
  13 in total

1.  Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR.

Authors:  Shoji Nagao; Mitsuo Yoshinouchi; Yasunari Miyagi; Atsushi Hongo; Junichi Kodama; Sachio Itoh; Takafumi Kudo
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies.

Authors:  Angel Cid-Arregui; Victoria Juárez; Harald zur Hausen
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.

Authors:  Hugo Arias-Pulido; Cheri L Peyton; Nancy E Joste; Hernan Vargas; Cosette M Wheeler
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  Study of viral integration of HPV-16 in young patients with LSIL.

Authors:  G Gallo; M Bibbo; L Bagella; A Zamparelli; F Sanseverino; M R Giovagnoli; A Vecchione; A Giordano
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

5.  Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR.

Authors:  Krzysztof Lukaszuk; Joanna Liss; Izabela Wozniak; Janusz Emerich; Czesław Wójcikowski
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

6.  The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.

Authors:  Wei Li; Wei Wang; Mani Si; Linfei Han; Qinglei Gao; Aiyue Luo; Yan Li; Yunping Lu; Shixuan Wang; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-14       Impact factor: 4.553

Review 7.  Human papillomavirus and cervical cancer.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

8.  An Exonuclease V-qPCR Assay to Analyze the State of the Human Papillomavirus 16 Genome in Cell Lines and Tissues.

Authors:  Julia E Myers; Katarzyna Zwolinska; Martin J Sapp; Rona S Scott
Journal:  Curr Protoc Microbiol       Date:  2020-12

9.  Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.

Authors:  Anna Gillio-Tos; Maria da Graça Bicalho; Valentina Fiano; Chiara Grasso; Valentina Tarallo; Laura De Marco; Morena Trevisan; Marinabarbaradesousa Xavier; Renata Slowik; Newton S Carvalho; Carlos A Maestri; Hadriano M Lacerda; Daniela Zugna; Lorenzo Richiardi; Franco Merletti
Journal:  BMC Cancer       Date:  2012-12-24       Impact factor: 4.430

10.  Application of multiplex PCR for Rapid and sensitive detection of human papillomaviruses in cervical cancer.

Authors:  Fateme Zandnia; Abbas Doosti; Abbas Mokhtari-Farsani; Mohammad Taghi Kardi; Abolfazl Movafagh
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.